JP2018533601A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2018533601A5 JP2018533601A5 JP2018524369A JP2018524369A JP2018533601A5 JP 2018533601 A5 JP2018533601 A5 JP 2018533601A5 JP 2018524369 A JP2018524369 A JP 2018524369A JP 2018524369 A JP2018524369 A JP 2018524369A JP 2018533601 A5 JP2018533601 A5 JP 2018533601A5
- Authority
- JP
- Japan
- Prior art keywords
- oral pharmaceutical
- pharmaceutical formulation
- formulation according
- oral
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Claims (20)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2021213640A JP2022058446A (en) | 2015-11-13 | 2021-12-28 | Formulations of l-ornithine phenylacetate |
Applications Claiming Priority (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562255300P | 2015-11-13 | 2015-11-13 | |
US62/255,300 | 2015-11-13 | ||
US201662276754P | 2016-01-08 | 2016-01-08 | |
US62/276,754 | 2016-01-08 | ||
US15/133,087 | 2016-04-19 | ||
US15/133,087 US20160338982A1 (en) | 2015-04-20 | 2016-04-19 | Formulations of l-ornithine phenylacetate |
PCT/US2016/061678 WO2017083758A1 (en) | 2015-11-13 | 2016-11-11 | Formulation of l-ornithine phenylacetate |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021213640A Division JP2022058446A (en) | 2015-11-13 | 2021-12-28 | Formulations of l-ornithine phenylacetate |
Publications (3)
Publication Number | Publication Date |
---|---|
JP2018533601A JP2018533601A (en) | 2018-11-15 |
JP2018533601A5 true JP2018533601A5 (en) | 2019-12-19 |
JP7294807B2 JP7294807B2 (en) | 2023-06-20 |
Family
ID=58695607
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2018524369A Active JP7294807B2 (en) | 2015-11-13 | 2016-11-11 | L-ornithine phenylacetate formulation |
JP2021213640A Pending JP2022058446A (en) | 2015-11-13 | 2021-12-28 | Formulations of l-ornithine phenylacetate |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2021213640A Pending JP2022058446A (en) | 2015-11-13 | 2021-12-28 | Formulations of l-ornithine phenylacetate |
Country Status (12)
Country | Link |
---|---|
EP (1) | EP3373923A4 (en) |
JP (2) | JP7294807B2 (en) |
KR (1) | KR20180086431A (en) |
CN (2) | CN113768863A (en) |
AU (2) | AU2016353350B2 (en) |
BR (1) | BR112018009349A8 (en) |
CA (1) | CA3004331A1 (en) |
IL (1) | IL258630B2 (en) |
MX (2) | MX2018005088A (en) |
RU (1) | RU2018113801A (en) |
SG (1) | SG11201802987UA (en) |
WO (1) | WO2017083758A1 (en) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JOP20190146A1 (en) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | Amino acid compositions and methods for the treatment of liver diseases |
SG11202001142VA (en) | 2017-08-14 | 2020-03-30 | Axcella Health Inc | Amino acid compositions for the treatment of liver disease |
MA52971A (en) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | COMPOSITIONS AND METHODS FOR THE TREATMENT OF FAT INFILTRATION IN THE MUSCLE |
BR112022007268A2 (en) * | 2019-10-16 | 2022-07-05 | Ocera Therapeutics Inc | DOSAGE AND USES OF ORNITINE PHENYLACTATE FOR THE TREATMENT OF HYPERAMMONEMIA |
Family Cites Families (11)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4783443A (en) | 1986-03-03 | 1988-11-08 | The University Of Chicago | Amino acyl cephalosporin derivatives |
AU2005308622B2 (en) | 2004-11-26 | 2012-08-02 | Ucl Business Plc | Compositions comprising ornithine and phenylacetate or phenylbutyrate for treating hepatic encephalopathy |
GB0426141D0 (en) * | 2004-11-26 | 2004-12-29 | Ucl Biomedica Plc | Treatment |
DE102007009243A1 (en) * | 2007-02-22 | 2008-09-18 | Evonik Röhm Gmbh | Pellets with a drug matrix and a polymer coating, and a method for producing the pellets |
NZ619235A (en) * | 2009-04-03 | 2015-06-26 | Ocera Therapeutics Inc | L-ornithine phenyl acetate and methods of making thereof |
AU2015221466B2 (en) | 2009-04-03 | 2017-02-02 | Ocera Therapeutics, Inc. | L-ornithine phenyl acetate and methods of making thereof |
EP3517110A1 (en) | 2009-06-08 | 2019-07-31 | UCL Business PLC | Treatment of inflammation using l-ornithine phenylacetate |
AU2014250643B2 (en) | 2009-06-08 | 2016-07-14 | Ocera Therapeutics, Inc. | Treatment of portal hypertension and restoration of liver function using L-ornithine phenylacetate |
WO2012048043A1 (en) * | 2010-10-06 | 2012-04-12 | Ocera Therapeutics, Inc. | Methods of making l-ornithine phenyl acetate |
CN103705490B (en) * | 2013-10-31 | 2016-08-17 | 蚌埠丰原医药科技发展有限公司 | The slow releasing preparation of a kind of aspartic acid ornithine and preparation technology thereof |
AU2016252382A1 (en) * | 2015-04-20 | 2017-11-02 | Ocera Therapeutics, Inc. | Formulations of L-ornithine phenylacetate |
-
2016
- 2016-11-11 SG SG11201802987UA patent/SG11201802987UA/en unknown
- 2016-11-11 CN CN202111062923.6A patent/CN113768863A/en active Pending
- 2016-11-11 KR KR1020187016373A patent/KR20180086431A/en not_active Application Discontinuation
- 2016-11-11 AU AU2016353350A patent/AU2016353350B2/en not_active Ceased
- 2016-11-11 MX MX2018005088A patent/MX2018005088A/en unknown
- 2016-11-11 BR BR112018009349A patent/BR112018009349A8/en not_active Application Discontinuation
- 2016-11-11 RU RU2018113801A patent/RU2018113801A/en not_active Application Discontinuation
- 2016-11-11 CN CN201680066488.5A patent/CN108366983A/en active Pending
- 2016-11-11 JP JP2018524369A patent/JP7294807B2/en active Active
- 2016-11-11 WO PCT/US2016/061678 patent/WO2017083758A1/en active Application Filing
- 2016-11-11 EP EP16865158.6A patent/EP3373923A4/en not_active Withdrawn
- 2016-11-11 CA CA3004331A patent/CA3004331A1/en active Pending
-
2018
- 2018-04-11 IL IL258630A patent/IL258630B2/en unknown
- 2018-04-25 MX MX2022001517A patent/MX2022001517A/en unknown
-
2021
- 2021-12-21 AU AU2021290236A patent/AU2021290236A1/en not_active Abandoned
- 2021-12-28 JP JP2021213640A patent/JP2022058446A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP2018513171A5 (en) | ||
JP2015503593A5 (en) | ||
JP2018533601A5 (en) | ||
HRP20192133T1 (en) | Chemical compound useful as intermediate for preparing a catechol-o-methyltransferase inhibitor | |
RU2017137643A (en) | COMPOSITIONS OF L-ORNITIN PHENYLACETATE | |
RU2018114447A (en) | INTRODUCTION OF CFTER DUTERED AMPLIFIERS | |
JP2015083580A5 (en) | ||
JP2008520736A5 (en) | ||
JP2013505205A5 (en) | ||
RU2016124765A (en) | APPLICATION OF RG3 GINSENOSIDE IN THE PREPARATION OF A MEDICINAL PRODUCT FOR PREVENTION AND / OR TREATMENT OF DEMENTIA, AND A MEDICINAL PRODUCT FOR THE TREATMENT OF DEMENTIA | |
CA2709997A1 (en) | Pirfenidone treatment for patients with atypical liver function | |
JP2012193216A5 (en) | ||
JP2016534081A5 (en) | Method for preparing an oral dosage form with enhanced oral bioavailability of zoledronic acid | |
BR122023026625A2 (en) | USE OF 15-HYDROXYEICOSAPENTAENOIC ACID OR PHARMACEUTICALLY ACCEPTABLE DERIVATIVES THEREOF | |
RU2018113801A (en) | Compositions of L-Ornithine Phenylacetate | |
MX2018000084A (en) | Pharmaceutical composition containing amlodipine, valsartan, and rosuvastatin. | |
HRP20200473T1 (en) | Dimethylaminomicheliolide for use in the treatment of pulmonary fibrosis | |
RU2018146504A (en) | Treatment of intrahepatic cholestatic diseases | |
IL272834B1 (en) | Amantadine compositions, preparations thereof, and methods of use | |
JP2015531749A5 (en) | ||
JP2016512247A5 (en) | ||
JP2016505050A5 (en) | ||
JP2017507142A5 (en) | ||
RU2018104691A (en) | COMPOSITIONS WITH MODIFIED NICERGOLINE RELEASE | |
JP2014510780A5 (en) |